亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Migraine with aura

光环 皮质扩散性抑郁症 先兆偏头痛 心理学 偏头痛 医学 冲程(发动机) 精神科 机械工程 工程类
作者
Christian Lucas
出处
期刊:Revue Neurologique [Elsevier BV]
卷期号:177 (7): 779-784 被引量:49
标识
DOI:10.1016/j.neurol.2021.07.010
摘要

Around 15% to one-third of migraineurs experience aura. Aura is a fully reversible focal neurological phenomenon involving visual, sensory, speech, and/or motor symptoms that develops gradually and usually precedes the headache phase. The pivotal role of cortical spreading depression (CSD) as a mechanism underlying aura has been widely supported by a large body of studies. The diagnosis is based on the International Headache Classification Disorders III edition criteria. Aura is characterized by gradual development, duration of each symptom no longer than one hour, a mix of positive and negative features, and complete reversibility. Visual aura is the most common type of aura, occurring in over 90% of patients. When aura symptoms are multiple, they usually follow one another in succession, beginning with visual, then sensory, then aphasic; but the reverse and other orders have been noted. The accepted duration for most aura symptoms is one hour, but motor symptoms, which are rare, are often longer lasting. When a patient experiences for the first time a possible aura phase it's sometimes difficult to know if there was gradual or brutal onset of the symptoms. If the patient has no visual aura symptoms or simultaneous neurological symptoms, or presents neurological symptoms corresponding to a cerebral vascular territory, emergency exploration of a possible transient ischemic attack is necessary. Long duration (greater than one hour) of what may or may not be an aura phase, late onset of aura, or a dramatic increase in aura attacks should also be explored. The relative risk of ischemic stroke is significantly increased in migraine with aura. Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. It is recommended to start non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin as soon as possible during the aura phase, not to treat the aura, but to avoid or to diminish the headache phase. In case of failure of NSAIDs or aspirin it is recommended to use a triptan when the headache begins. The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无尾熊完成签到 ,获得积分10
1秒前
1秒前
14秒前
贰壹完成签到 ,获得积分10
16秒前
今日应助唐泽雪穗采纳,获得130
18秒前
19秒前
20秒前
21秒前
王红玉发布了新的文献求助10
23秒前
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
完美世界应助科研通管家采纳,获得10
24秒前
领导范儿应助科研通管家采纳,获得10
24秒前
24秒前
25秒前
26秒前
28秒前
brian0326发布了新的文献求助10
28秒前
唐唐完成签到 ,获得积分10
35秒前
brian0326完成签到,获得积分10
37秒前
唐泽雪穗发布了新的文献求助130
38秒前
激动的鹰完成签到,获得积分10
41秒前
doctor2023完成签到,获得积分10
46秒前
50秒前
turtle完成签到 ,获得积分10
52秒前
彭于晏应助ling采纳,获得10
54秒前
sweet完成签到 ,获得积分10
57秒前
1分钟前
犹豫幻丝完成签到,获得积分10
1分钟前
1分钟前
JIA发布了新的文献求助10
1分钟前
Eason_C完成签到 ,获得积分10
1分钟前
李姝仪完成签到 ,获得积分10
1分钟前
不抛弃不放弃完成签到,获得积分20
1分钟前
zhongxia完成签到 ,获得积分10
1分钟前
1分钟前
Isaac完成签到 ,获得积分10
1分钟前
1分钟前
ling发布了新的文献求助10
1分钟前
orixero应助JIA采纳,获得10
1分钟前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
LRZ Gitlab附件(3D Matching of TerraSAR-X Derived Ground Control Points to Mobile Mapping Data 附件) 2000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
The Social Work Ethics Casebook(2nd,Frederic G. R) 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
Huang's Catheter Ablation of Cardiac Arrhythmias 5th Edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5126532
求助须知:如何正确求助?哪些是违规求助? 4329993
关于积分的说明 13492545
捐赠科研通 4165169
什么是DOI,文献DOI怎么找? 2283273
邀请新用户注册赠送积分活动 1284262
关于科研通互助平台的介绍 1223847